TP53 encodes the p53 protein, a critical tumor suppressor that acts as a transcription factor to protect cells from damage. When activated by cellular stress such as DNA damage, p53 triggers responses including DNA repair, cell cycle arrest, and programmed cell death (apoptosis) to prevent the propagation of damaged cells. TP53 is the most frequently mutated gene in human cancers, and loss of its function contributes to tumor development, invasion, drug resistance, and genomic instability. Inherited mutations in TP53 cause Li-Fraumeni syndrome, a rare hereditary condition that greatly increases the risk of developing multiple types of cancer at a young age.

TP53 is a critical tumor suppressor, and inherited variants cause Li-Fraumeni syndrome, a hereditary condition of greatly elevated, early-onset cancer risk. This missense change at codon 334 shows partial loss of function in laboratory assays, yet evidence is still insufficient to confirm or exclude pathogenicity, so it remains a variant of uncertain significance pending further clinical and family data.